How Casperome® Boswellia Differs from Standard Boswellia Extracts
April 22, 20252 min read
Casperome is a phytosome formulation of boswellic acids — boswellia extract complexed with phosphatidylcholine — that achieves dramatically higher blood levels than standard boswellia extracts, translating into stronger clinical effects for joint comfort and inflammatory support.
The Bioavailability Problem with Standard Boswellia
Boswellic acids — particularly AKBA (acetyl-11-keto-beta-boswellic acid) — are potent inhibitors of 5-lipoxygenase (5-LOX), the enzyme that produces inflammatory leukotrienes. Leukotrienes are key mediators of chronic joint inflammation, making boswellia theoretically ideal for joint support. The problem: standard boswellia extracts are poorly absorbed. Boswellic acids are lipophilic (fat-loving) compounds with low aqueous solubility, resulting in poor and variable bioavailability from conventional capsules. Much of the ingested boswellia passes through the GI tract without reaching meaningful blood levels.
How Casperome Solves This
Casperome uses Phytosome technology — complexing boswellic acids with phosphatidylcholine (a phospholipid that forms cell membranes). This creates a lipid-compatible structure that crosses the intestinal wall far more efficiently than free boswellic acids. Pharmacokinetic studies show Casperome achieves blood levels of AKBA that are significantly higher than equivalent doses of standard boswellia extract — translating directly into stronger clinical anti-inflammatory effects.
Clinical Evidence
Casperome has been studied in multiple clinical trials for osteoarthritis, showing significant improvements in WOMAC pain and function scores compared to placebo and compared to standard boswellia extracts. It has also shown benefit for exercise-induced joint stress in athletes and for inflammatory markers in metabolic conditions. Inflavinol provides Casperome alongside curcumin for dual-pathway inflammatory support — 5-LOX inhibition from boswellia plus NF-kB modulation from curcumin.
For clinical effectiveness, yes — the enhanced bioavailability translates into stronger anti-inflammatory effects at practical doses. Standard boswellia may provide some benefit at high doses, but Casperome delivers more consistent, clinically relevant blood levels.
Can I take Casperome with curcumin?
Yes — they work through complementary anti-inflammatory mechanisms. Boswellia inhibits 5-LOX (reducing leukotrienes), while curcumin modulates NF-kB (reducing a broader range of inflammatory mediators). The combination provides more comprehensive inflammatory pathway coverage than either alone.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
